Daniel Santos1, Jeannette R Mahoney1, Gilles Allali1,2, Joe Verghese1. 1. Department of Neurology, Division of Cognitive & Motor Aging, Albert Einstein College of Medicine, Bronx, New York. 2. Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Switzerland.
Abstract
Background: Physical activity regimens are beneficial for older adults with Parkinson's disease; however, their beneficial effect on individuals with mild parkinsonian signs (MPS) who do not meet criteria for Parkinson's disease is not established. The current observational study aims to determine the cognitive and motor impact of physical activity in older adults with MPS over a 1-year period. Methods: Three hundred and forty-one individuals underwent medical and neurologic assessment of MPS at baseline. MPS was diagnosed using the motor portion of the Unified Parkinson Disease Rating Scale. Physical activity frequency (days/month) were recorded at baseline and 1-year follow-up along with Repeatable Battery for Assessment of Neuropsychological Status (RBANS) score and gait velocity during normal walking (NW) and walking while talking (WWT) conditions. Associations over the 1-year period were assessed using linear regressions controlling for key covariates. Results: One hundred and thirty (38.1%) participants met criteria for MPS. These participants demonstrated significant associations between physical activity and gait velocity at baseline (NW: p < .01; WWT: p = .03) and follow-up (NW: p < .01; WWT: p = .02). Physical activity was also associated with RBANS total score (p < .01) at follow-up. Increases in physical activity frequency over 1 year were associated with increases in NW velocity (p = .02), WWT velocity (p < .01), and RBANS total score (p < .01). Conclusions: Among older adults with MPS, increased frequency of physical activity is associated with decreased risk of cognitive and motor decline. Our results highlight the importance of participation in physical activities on maintaining motor and cognitive functioning in older adults with MPS.
Background: Physical activity regimens are beneficial for older adults with Parkinson's disease; however, their beneficial effect on individuals with mild parkinsonian signs (MPS) who do not meet criteria for Parkinson's disease is not established. The current observational study aims to determine the cognitive and motor impact of physical activity in older adults with MPS over a 1-year period. Methods: Three hundred and forty-one individuals underwent medical and neurologic assessment of MPS at baseline. MPS was diagnosed using the motor portion of the Unified Parkinson Disease Rating Scale. Physical activity frequency (days/month) were recorded at baseline and 1-year follow-up along with Repeatable Battery for Assessment of Neuropsychological Status (RBANS) score and gait velocity during normal walking (NW) and walking while talking (WWT) conditions. Associations over the 1-year period were assessed using linear regressions controlling for key covariates. Results: One hundred and thirty (38.1%) participants met criteria for MPS. These participants demonstrated significant associations between physical activity and gait velocity at baseline (NW: p < .01; WWT: p = .03) and follow-up (NW: p < .01; WWT: p = .02). Physical activity was also associated with RBANS total score (p < .01) at follow-up. Increases in physical activity frequency over 1 year were associated with increases in NW velocity (p = .02), WWT velocity (p < .01), and RBANS total score (p < .01). Conclusions: Among older adults with MPS, increased frequency of physical activity is associated with decreased risk of cognitive and motor decline. Our results highlight the importance of participation in physical activities on maintaining motor and cognitive functioning in older adults with MPS.
Authors: Joe Verghese; Herman Buschke; Lisa Viola; Mindy Katz; Charles Hall; Gail Kuslansky; Richard Lipton Journal: J Am Geriatr Soc Date: 2002-09 Impact factor: 5.562
Authors: Patrick J Smith; James A Blumenthal; Benson M Hoffman; Harris Cooper; Timothy A Strauman; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Andrew Sherwood Journal: Psychosom Med Date: 2010-03-11 Impact factor: 4.312
Authors: Yves Rolland; Fabien Pillard; Adrian Klapouszczak; Emma Reynish; David Thomas; Sandrine Andrieu; Daniel Rivière; Bruno Vellas Journal: J Am Geriatr Soc Date: 2007-02 Impact factor: 5.562
Authors: Shahram Oveisgharan; Lei Yu; Robert J Dawe; David A Bennett; Aron S Buchman Journal: J Gerontol A Biol Sci Med Sci Date: 2020-03-09 Impact factor: 6.053
Authors: Jennifer C Arnold; Mark A Cantu; Ella A Kasanga; Vicki A Nejtek; Evan V Papa; Nicoleta Bugnariu; Michael F Salvatore Journal: PLoS One Date: 2017-11-27 Impact factor: 3.240
Authors: Ella A Kasanga; Joel Little; Tamara R McInnis; Nicoleta Bugnariu; J Thomas Cunningham; Michael F Salvatore Journal: Front Aging Neurosci Date: 2021-12-15 Impact factor: 5.750